Albireo Pharma Inc (ALBO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2008 | 09-2008 | 06-2008 | 03-2008 | 12-2007 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -10,024 | N/A | -30,696 | -20,584 | -11,025 |
| Depreciation Amortization | 209 | N/A | 386 | 201 | 68 |
| Accounts payable and accrued liabilities | -743 | N/A | -1,777 | 690 | 2,073 |
| Other Working Capital | -730 | N/A | 307 | 1,880 | 2,047 |
| Other Operating Activity | 1,969 | 0 | 7,876 | 3,545 | 415 |
| Operating Cash Flow | $-9,319 | $N/A | $-23,904 | $-14,268 | $-6,422 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 7,536 | N/A | -31,007 | -3,803 | N/A |
| PPE Investments | -25 | N/A | -2,191 | -1,837 | -1,044 |
| Purchase Sale Intangibles | N/A | N/A | -31 | -28 | -10 |
| Other Investing Activity | 0 | 0 | -31 | -28 | -10 |
| Investing Cash Flow | $7,511 | $N/A | $-33,229 | $-5,668 | $-1,054 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 26 | N/A | 47,978 | 47,798 | 219 |
| Financing Cash Flow | $26 | $N/A | $47,978 | $47,798 | $219 |
| Beginning Cash Position | 64,731 | N/A | 80,022 | 80,022 | 80,022 |
| End Cash Position | 62,949 | N/A | 70,867 | 107,884 | 72,765 |
| Net Cash Flow | $-1,782 | $N/A | $-9,155 | $27,862 | $-7,257 |
| Free Cash Flow | |||||
| Operating Cash Flow | -9,319 | N/A | -23,904 | -14,268 | -6,422 |
| Capital Expenditure | -25 | N/A | -2,191 | -1,837 | -1,044 |
| Free Cash Flow | -9,344 | 0 | -26,095 | -16,105 | -7,466 |